Gene · 163702
Papers1,320
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,320
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interferon-λ receptor positive monocytes/macrophages orchestrate a pro-fibrotic immune environment in hepatitis B virus-related liver fibrosis. | Clin Sci (Lond) | 2026 | 42742113 | PubTator, text mining | PubMed |
| Triple IFN pathway deficiency sensitizes mice to human respiratory virus infection independent of human viral receptor expression. | Nat Commun | 2026 | 42463654 | PubTator, text mining | PubMed |
| Subtype-specific functions of basal IFNλs. | J Virol | 2026 | 42227763 | PubTator, text mining | PubMed |
| Mechanisms of Differential Signal Transduction by Interferon Lambda Receptor 1 Variants. | J Innate Immun | 2026 | 42213608 | PubTator, text mining | PubMed |
| Mapping the Causal Landscape of Psoriasis: A Systematic Mendelian Randomization Evidence Synthesis and Development of the MR-PsO Atlas Platform. | Exp Dermatol | 2026 | 42157626 | PubTator, text mining | PubMed |
| Interferon lambda in anti-viral defense and cancer: dual roles, mechanism and therapeutic potential. | J Transl Med | 2026 | 42092929 | PubTator, text mining | PubMed |
| Dual regulation of antiviral IFN response by Scutellariae Radix: Therapeutic implications for influenza. | J Pharm Anal | 2026 | 41960576 | PubTator, text mining | PubMed |
| Interferon dynamics in deltaretroviruses: why HTLV-1 evades, but BLV responds. | Mol Biol Rep | 2026 | 41920397 | PubTator, text mining | PubMed |
| Multi‑omics and their integration in psoriasis research (Review). | Mol Med Rep | 2026 | 41891974 | PubTator, text mining | PubMed |
| MERS-CoV and SARS-CoV-1 proteins inhibit the IFN-α JAK/STAT pathway of epithelial cells, via IFN-λ-induced USP18. | Front Immunol | 2026 | 41798916 | PubTator, text mining | PubMed |
| Interplay between flaviviruses and the interferon response: mechanisms of immune evasion and therapeutic implications. | Front Pharmacol | 2026 | 41788799 | PubTator, text mining | PubMed |
| Experimental adaptation of pigeon rotavirus A (pRVA) in human colorectal cancer cells reveals interferon-driven host responses and immune checkpoint modulation. | New Microbes New Infect | 2026 | 41783245 | PubTator, text mining | PubMed |
| HIV-seq reveals gene expression differences between HIV-transcribing cells from viremic and suppressed people with HIV. | Nat Commun | 2026 | 41776157 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs Can Govern the Antiviral Immune Response Through Interferon-Mediated Mechanisms in Respiratory Tract. | Viruses | 2026 | 41754574 | PubTator, text mining | PubMed |
| Beyond Viral Restriction: The Metabolic Dimensions of Interferon-Stimulated Genes in Antiviral Immunity. | Viruses | 2026 | 41754503 | PubTator, text mining | PubMed |
| Protease Inhibitors and Innate Immune Agonists as Antiviral Strategies Against Dengue and Zika Viruses. | Pathogens | 2026 | 41754484 | PubTator, text mining | PubMed |
| Alpha-1B Glycoprotein Is a Novel Hepatocyte-Derived Host Factor Associated with In Vitro Inhibition of HBV Replication and Hepatocellular Carcinoma Progression. | Cancers (Basel) | 2026 | 41749914 | PubTator, text mining | PubMed |
| Interferon lambda signaling to maternal dendritic cells protects against congenital Zika virus infection. | bioRxiv | 2026 | 41659402 | PubTator, text mining | PubMed |
| Nanoparticle approaches for hepatitis therapy and clinical translation. | Discov Nano | 2026 | 41649705 | PubTator, text mining | PubMed |
| Dose-dependent activation of the Hippo pathway by Type I and Type III interferons suppresses tissue repair by human bronchial epithelial cells. | PLoS Biol | 2026 | 41587178 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/163702/papers